Tucaxen Tablets contain the active ingredient Tucatinib, a potent tyrosine kinase inhibitor specifically designed for the treatment of HER2-positive breast cancer. This medication functions by selectively targeting and inhibiting the HER2 protein responsible for promoting the proliferation of cancer cells, thereby slowing tumor growth and progression. Tucaxen is especially indicated for patients with advanced or metastatic HER2-positive breast cancer who have previously undergone other treatment regimens. The tablets are formulated under stringent pharmaceutical quality controls to ensure consistent dosage, efficacy, and patient safety. Careful adherence to prescribed dosage and regular medical monitoring are essential to maximize therapeutic benefits and manage possible side effects. Tucaxen represents a modern targeted cancer therapy option, providing oncologists and healthcare providers a specialized tool in managing complex breast cancer cases.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Tucatinib |
| Therapeutic Class | Tyrosine Kinase Inhibitor |
| Indication | Treatment of HER2-positive advanced or metastatic breast cancer |
| Mechanism of Action | Selective inhibition of HER2 protein to slow cancer cell growth |
| Dosage Form | Oral Tablets |
| Targeted Therapy | Specifically targets HER2 receptor-positive tumors |
| Manufacturing Standards | Produced under strict pharmaceutical quality controls |
| Patient Monitoring | Requires regular clinical monitoring for efficacy and side effects |
| Attributes | Description |
|---|---|
| Dosage Strength | Specific strength as prescribed by healthcare provider |
| Packaging | Blister packs with specified number of tablets |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Shelf Life | As indicated by batch-specific expiration date |
| Usage Instructions | Take orally as per oncologist's prescription |
| Patient Eligibility | Suitable for HER2-positive advanced or metastatic breast cancer patients |
| Side Effects Monitoring | Patients should be monitored for known side effects including diarrhea, hepatotoxicity, and fatigue |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Tucaxen (Tucatinib) Tablets are typically prescribed for advanced or metastatic HER2-positive breast cancer patients who have received prior treatments rather than as a first-line therapy.
Patients on Tucaxen should be regularly monitored for side effects including liver function tests due to potential hepatotoxicity, assessment of gastrointestinal tolerance (such as diarrhea), and overall therapeutic response.
Yes, Tucaxen is often used in combination regimens as prescribed by an oncologist, particularly with chemotherapy agents, to enhance therapeutic outcomes in HER2-positive breast cancer.
Tucaxen Tablets should be stored in a cool, dry place, protected from direct sunlight and moisture to preserve tablet efficacy and shelf life.
Inclusive of all taxes
You Save: 0
Bengaluru , India
Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler
GST- 29AQTPJ8785C1Z2
